期刊文献+

吡格列酮对高糖高胰岛素诱导的心肌成纤维细胞增殖的影响 被引量:1

Effects of pioglitazone on cardiac fibroblast proliferation induced with high glucose and high insulin
下载PDF
导出
摘要 目的利用体外培养的乳鼠心肌成纤维细胞,观察噻唑烷二酮(TZD)类药物吡格列酮对高浓度葡萄糖与高浓度胰岛素共同诱导的心肌成纤维细胞增殖的影响,进一步推测TZD类药物对糖尿病并发心肌肥厚的可能作用机制。方法以培养的乳鼠心肌成纤维细胞为模型分组给药后。利用结晶紫染色法测定细胞的数量;利用[3H]thym id ine标记法测定细胞DNA的合成;利用流式细胞仪分析细胞周期。结果吡格列酮可以抑制高糖高胰岛素诱导的心肌成纤维细胞数量、DNA合成及S+G2+M期细胞的百分比增加,并呈一定的剂量依赖性。结论吡格列酮能有效抑制高糖高胰岛素诱导的心肌成纤维细胞的增殖,这种作用可能是通过作用于PPARγ来实现的。 Aim To study effects of pioglitazone on cardiac fibroblast proliferation induced with high glucose and high insulin. Methods The neonatal rat cardiac fibroblasts were cultured and treated with different factors. The cellular number was determined by crystal violet uptake; the DNA synthesis was assayed with [ 3 ^H ] thymidine intake method ; the percentage of S + G2 + M in the cell cycle was determined by flow cytometry. Results Pioglitazone inhibited the cell number.DNA synthesis and the percentage of S + G2 + M inthe cell cycle of cultured cardiac fibroblasts induced with high glucose and high insulin. Conclusion Pioglitazone inhibits cardiac fibroblast proliferation induced with high glucose and high insulin and the effective mechanism of pioglitazone on cardiac fibroblast proliferation needs further study.
出处 《中国药理学通报》 CAS CSCD 北大核心 2006年第10期1246-1249,共4页 Chinese Pharmacological Bulletin
关键词 吡格列酮 高糖 高胰岛素 成纤维细胞 增殖 pioglitazone high glucose high insulin cardiac fibroblast proliferation
  • 相关文献

参考文献9

二级参考文献16

  • 1刘海林,杨少平,陆汉明,李定国,蒋祖明.维拉帕米、硝苯地平对人成纤维细胞增殖、胶原和透明质酸合成的抑制作用[J].中国药理学通报,1996,12(5):456-458. 被引量:15
  • 2张双喜 汪谦.流式细胞术.现代医学实验方法[M].北京:人民卫生出版社,1997.887-899.
  • 3孙海励 余振球 等.胰岛素与高血压的关系.实用高血压学(第1版)[M].北京:科学出版社,1993.91-103.
  • 4Sakai S, Miyauchi T, Irukayama-Tomobe Y et al. Peroxisome proliferator-activated receptor gamma activators inhibit endothelin-1related cardiac hypertrophy in rats[J]. Clin Sci,2002,103( Suppl48) :16 -20.
  • 5Keiji Yamamoto, Ruri Ohki, Richard T Lee et al. Peroxisome proliferator-activated receptor γ activators inhibit cardiac hypertrophy in cardiac myocytes[J]. Circulation ,2001,104:1670 - 81.
  • 6Williams B, Tsai P, Schrier RW. Glucose-induced down-regulation of angiotensin and arginine vasopressin receptore in cultured rat aortic vascular smooth muscle cells[ J]. J Clin Invest, 1992,90(5) :1992 -9.
  • 7Molkentin JD, Lu J-R, Antos CL et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy[J]. Cell, 1998,93(2) :215 -28.
  • 8Ricote M, Li AC, Willson TM et al. The peroxisome prolix-ferator-activated receptor γ is a negative regulator of macrophage activation[J]. Nature, 1998,391 ( 6662 ): 79 - 82.
  • 9Fuller SJ, Davies EL, Gillespie BJ et al. Mitogen-activated protein kinase phosphatase 1 inhibits the stimulation of expression by hypertrophic agonists in cardiac myocytes [J]. Biochem J, 1997,323( Pt 2) :313 -9.
  • 10De Vos P, Lefebvre AM, Miller SG et al. Thiazolidinediones repress obgene expression in rodents via activation of peroxisome proliferators-activated receptory[J]. J Clin Invest, 1996,98 (4): 1004-9.

共引文献37

同被引文献13

  • 1周庆峰,王洪新,王怡薇,单丹,符丽娟.吡格列酮对高糖高胰岛素诱导的心肌细胞肥大的影响[J].中国药理学通报,2004,20(7):818-821. 被引量:8
  • 2Mehrabi MR,Thalhammer T,Haslmayer P,Glogar HD,Wieselthaler G,Humpeler S,et al.The peroxisome proliferator-activated receptor gamma (PPARgamma) is highly expressed in human heart ventricles[J].Biomed Pharmacother,2002,56(8):407-410.
  • 3Wayman NS,Hattori Y,McDonald MC,Mota-Filipe H,Cuzzocrea S,Pisano B,et al.Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size[J].FASEB J,2002,16(9):1027-1040.
  • 4Cao Z,Ye P,Long C,Chen K,Li X,Wang H.Effect of pioglitazone,a peroxisome proliferator-activated receptor gamma agonist,on ischemia-reperfusion injury in rats[J].Pharmacology,2007,79(3):184-192.
  • 5Li J,Lang MJ,Mao XB,Tian L,Feng YB.Antiapoptosis and mitochondrial effect of pioglitazone preconditioning in the ischemic/reperfused heart of rat[J].Cardiovasc Drugs Ther,2008,22(4):283-291.
  • 6Wang HX,Kwan CY,Wong TM.Electrically induced intracellular Ca2+ transient in single ventricular myocytes:a useful parameter for the study of cardiac drugs[J].Clin Exp Pharmacol Physiol,1999,26(10):835-836.
  • 7Dhalla NS,Temsah RM,Netticadan T.Role of oxidative stress in cardiovascular diseases[J].J Hypertens,2000,18(6):655-673.
  • 8Venardos K,Harrison G,Headrick J,Perkins A.Auranofin increases apoptosis and ischaemia-reperfusion injury in the rat isolated heart[J].Clin Exp Pharmacol Physiol,2004,31(5-6):289-294.
  • 9El Midaoui A,Wu L,Wang R,de Champlain J.Modulation of cardiac and aortic peroxisome proliferator-activated receptor-gamma expression by oxidative stress in chronically glucose-fed rats[J].Am J Hypertens,2006,19(4):407-412.
  • 10Tureyen K,Kapadia R,Bowen KK,Satriotomo I,Liang J,Feinstein DL,et al.Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive,normoglycemic as well as hypertensive and type-2 diabetic rodents[J].J Neurochem,2007,101(1):41-56.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部